Tuesday May 18th, 2021 7:15AM

Vaccine sales power Pfizer through first quarter

By The Associated Press
Related Articles
  Contact Editor

Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid performance across most of the company, is hiking its 2021 financial forecast sharply after blowing past Wall Street expectations for the first quarter.

The New York drugmaker and its German partner on the vaccine, BioNTech, continue to sign contracts with multiple countries for their two-dose shot. They reported $3.46 billion in first-quarter sales and now expect to rake in roughly $26 billion over the year, up from their prior forecast of about $15 billion.

The companies may soon receive U.S. and EU approval to give the vaccine to 12- through 15-year-olds and continue testing the vaccine in other patient groups, including pregnant women and children from six months to 11 years old.

The partners are also testing the efficacy of a booster shot of the vaccine, which may be needed — perhaps annually — to keep immunity high over time and to protect people from numerous emerging coronavirus variants that may spread more easily or be more deadly. And they're developing new vaccine versions that have a longer shelf life and don't require being kept frozen.

Pfizer on Tuesday reported net income of $4.88 billion, or 86 cents per share. That was up from $3.36 billion, or 60 cents per share, in 2020’s first quarter, when the global coronavirus pandemic began triggering lockdowns, and doctor visits and new prescriptions for other medicines dropped significantly.

Adjusted earnings, excluding one-time items, jumped 48% to $5.26 billion, or 93 cents per share, far above the 79 cents Wall Street was expecting, according to a survey by Zacks Investment Research. Revenue was $14.58 billion, also easily exceeding forecasts of $13.49 billion.

The maker of the blockbuster Prevnar vaccine against pneumococcal disease said even without COVID-19 vaccine sales, it is meeting its goal of increasing revenue by at least 6% each year through 2025.

“Excluding the growth provided from (the vaccine), our revenues grew 8% operationally,” Chief Executive Albert Bourla said in a prepared statement, adding, "In addition, we have achieved important clinical, regulatory and commercial milestones across our pipeline and portfolio while also continuing to increase our capacity to supply urgently-needed doses" of the COVID-19 vaccine."

Pfizer now expects to be able to deliver about 2.5 billion vaccine doses this year and already has signed contracts covering about 1.6 billion of those doses, including 200 million doses promised for the U.S. by the end of May and another 100 million doses later this year.

The company also has begun testing a pill to treat COVID-19.

Meanwhile, sales of cancer drugs jumped 18% in the quarter and sales of medicines administered in hospitals rebounded 11% as patients got treatments delayed by hesitance to go to hospitals swamped with COVID-19 patients. Sales of clot preventer Eliquis jumped 26% to $1.64 billion.

During the quarter, the U.S. Food and Drug Administration approved an additional use for Pfizer’s immunoglobulin drug Panzyga, for treating a rare condition that damages peripheral nerves. The FDA also approved use of the company’s Lorbrena as an initial treatment for non-small cell one cancer.

Pfizer noted the FDA is now reviewing its application for its experimental vaccine against tick-borne encephalitis, for people as young as age 1.

And while an updated version of its vaccine against pneumococcal disease awaits regulatory approval, Pfizer has begun testing the safety of administering that vaccine at the same time as a COVID-19 vaccine booster.

Pfizer now expects full-year earnings in the range of $3.55 to $3.65 per share, up from $3.10 to $3.20 per share in February, and revenue in the range of $70.5 billion to $72.5 billion, up from $59.4 billion to $61.4 billion in the February forecast.

In premarket trading, Pfizer shares rose 31 cents to $40.15.


Follow Linda A. Johnson at


A portion of this story was generated by Automated Insights ( using data from Zacks Investment Research.

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2021
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Vaccine sales power Pfizer through first quarter
Pfizer is raising its 2021 revenue expectations amid the successful rollout of its COVID-19 vaccine and strong performances from many  other medicines
8:11AM ( 12 minutes ago )
Mexico City metro overpass collapses onto road; 23 dead
Officials say an elevated section of Mexico City's metro collapsed and at least 23 people have been killed
8:07AM ( 16 minutes ago )
Storms spawn twisters in Mississippi, kill 2 in Georgia
Forecasters said much of the South could see more severe weather Tuesday
7:51AM ( 32 minutes ago )
Associated Press (AP)
World markets mixed after strong earnings, data lift Wall St
Shares are mixed in Europe and Asia after strong corporate earnings and data lifted stocks on Wall Street
5:20AM ( 3 hours ago )
G7 foreign ministers meet face-to-face after pandemic pause
Foreign ministers from the Group of Seven wealthy industrialized nations are gathering in London to grapple with threats to health, prosperity and democracy
4:29AM ( 3 hours ago )
The Latest: Kuwait to bar unvaccinated from traveling abroad
Kuwait’s government is barring unvaccinated residents from traveling abroad starting later this month, the latest attempt to tame the spiraling coronavirus outbreak in the Gulf Arab sheikhdom
3:58AM ( 4 hours ago )
AP Business
Asian shares mixed after strong earnings, data lift Wall St
Asian shares are mixed after strong corporate earnings and data lifted stocks on Wall Street
11:30PM ( 8 hours ago )
The Latest: Alabama gov says pandemic "absolutely" managed
Declaring the COVID-19 pandemic “absolutely” managed despite lagging vaccinations, Alabama Gov. Kay Ivey says she will end a state health order meant to guard against the spread of an illness that has killed nearly 11,000 people statewide
5:38PM ( 14 hours ago )
McConnell says GOP open to $600 billion for infrastructure
The top Republican in the Senate is opening the door to backing a smaller infrastructure bill
4:33PM ( 15 hours ago )
AP Business - Corporate News
The Latest: Sri Lanka receives 1st batch of Sputnik V shots
Sri Lanka has received its first batch of the Russia’s Sputnik V vaccine
11:51PM ( 8 hours ago )
The Latest: NKorea warns people to brace for virus struggle
Isolated North Korea is warning its people to brace for a prolonged struggle against the coronavirus, claiming that broadening outbreaks and muddled immunization programs in other countries show vaccines aren’t the ultimate solution
10:22PM ( 10 hours ago )
The Latest: Washington state to have vaccination sections
More people will be allowed at indoor and outdoor spectator events and indoor religious services if there are designated COVID-19 vaccination sections, under new guidance issued by Washington Gov. Jay Inslee
9:24PM ( 10 hours ago )
AP Business - Industries
The Latest: South Africa gets its first batch of vaccines
South Africa has received its first batch of the Pfizer vaccine
11:23AM ( 21 hours ago )
Wall Street logs early gains Monday on strong earnings
Stocks were solidly higher Monday, and investors cheered a strong dose of positive earnings reports as well as economic data that showed the U.S. economy is growing
10:31AM ( 21 hours ago )
Wall Street opening higher Monday on strong earnings
Stocks are rising on Wall Street early Monday, following markets in Europe higher on the back of strong gains by blue chip companies including Mohawk Industries, The Gap and Halliburton
9:47AM ( 22 hours ago )
AP Business - Health Care
Mexico City metro overpass collapses onto road; 23 dead
Officials say an elevated section of Mexico City's metro collapsed and at least 23 people have been killed
8:07AM ( 16 minutes ago )
Storms spawn twisters in Mississippi, kill 2 in Georgia
Forecasters said much of the South could see more severe weather Tuesday
7:51AM ( 32 minutes ago )
CVS take on 2021 gets rosier, profit jumps 11%
CVS Health beat Wall Street expectations and after releasing projections earlier this year that disappointed analysts, a new outlook Tuesday exceeds those levels
7:42AM ( 41 minutes ago )
Some Black parents say remote learning gives racism reprieve
As school districts across the country rush to reopen schools, national and state polling suggests parents of color are more wary of reopening than white parents
7:30AM ( 54 minutes ago )
Pfizer ups expectations for the year
Pfizer is raising its revenue expectations for the year with a huge roll out of its COVID-19 vaccine as well as strong performances from other parts of its business
7:13AM ( 1 hour ago )